SARS-CoV-2 BA.2.86 is less resistant to vaccine, but may be

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced an

Related Keywords

Ohio State University , Ohio , United States , Columbus , Richard Gumina , Joseph Bednash , Linda Saif , Daniel Jones , Jeffrey Horowitz , Eugene Oltz , Shan Lu Liu , Claire Carlin , Julia Faraone , Kai Xu , Emily Caldwell , Negin Goodarzi , Rama Mallampalli , Robertj Anthony Fund For Cardiovascular Research , Ohio State Infectious Diseases Institute , Ohio State Comprehensive Cancer Center , National Center , Translational Sciences , Centers For Disease , World Health Organization , Ohio State College Of Veterinary Medicine , Retrovirus Research , Department Of Microbial Infection , National Institutes Of Health , Pathogens Program , Veterinary Biosciences , Ohio State , Microbial Infection , Disease Control , Middle East , Emerging Pathogens Program , Infectious Diseases , National Institutes , Advancing Translational Sciences , Glenn Barber Fellowship , Veterinary Medicine , Cardiovascular Research , Comprehensive Cancer Center , Yi Min Zheng , Newswise , Ovid 19 Sars Cov 2 Ba 86 Variant Omicron Neutralizing Antibodies Covid Vaccination Spike Protein Mutations Lung ,